Korea Food Research Institute

Young Do Nam

So Young Lee

Hee Soon Shin

So Lim Park

Dong Uk Shin

Eun Sook Lee

Yong Sun Cho

Ji Eun Eom

Eun Ji Song

Jin Ju Bae

Sung Hun Yi

Dae Woon Choi

Seung Yong Kim

Sang Dong Lim

Won Hyong Chung

Myung Ki Lee

Sun Young Jung

The present invention relates to a food composition for enhancing respiratory function and improving respiratory diseases, usingKF511 strain; a health functional food comprising the food composition; and a pharmaceutical composition for preventing or treating the respiratory diseases, comprisingstrain, its culture solution, its concentrate, or its dried product, as an active ingredient.

Composition for improving respiratory diseases using Lactobacillus plantarum strain

The present invention relates to a composition comprising as an active ingredient a strain having excellent ability to produce formic acid for preventing or treating obesity or metabolic syndromes caused by obesity; and to a food composition and a health functional food each comprising the active ingredient. The strain having excellent ability to produce formic acid according to the present invention not only has effects of reducing body weight and inhibiting fat accumulation in organs, but also has activity to effectively lower blood triglyceride and cholesterol levels, and therefore, the composition comprising the strain as an active ingredient can be favorably used as a composition capable of preventing/alleviating or treating obesity or metabolic syndromes caused by obesity. Therefore, the strain having excellent ability to produce formic acid according to the present invention can be favorably used as a material for a medical product or health food.

Composition including, as active ingredient, strain having ability to produce formic acid for preventing or treating obesity or metabolic syndromes caused by obesity

A novelAO356 strain according to the present disclosure, which is a strain isolated from the human body, has high stability, exhibits the activity of inhibiting adipogenic differentiation in vitro and inducing the differentiation of M1 and M0 macrophages into M2 macrophages, and has excellent activity of alleviating, preventing, or treating obesity, such as the activity of reducing body weight and a reduction in blood lipid concentration through the browning of white fat in animal experiments. Thus, the novel strain of the present disclosure has a low possibility of causing side effects, and therefore, unlike conventional diet functional foods or drugs, which have side effect problems, a diet effect can be exhibited without controlling the dose thereof. Accordingly, the novel strain can be used as a pharmaceutical composition for treating or preventing obesity or a food composition for alleviating or preventing obesity.

AO356 strain having anti-obesity activity and method for preventing, alleviating or treating obesity using the same

Growing community of inventors

Seongnam-si, South Korea

Young Do Nam